Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥1,193 JPY
Change Today +3.00 / 0.25%
Volume 135.4K
4571 On Other Exchanges
As of 2:00 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

nanocarrier co ltd (4571) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/25/14 - ¥2,156
52 Week Low
05/21/14 - ¥885.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANOCARRIER CO LTD (4571)

Related News

No related news articles were found.

nanocarrier co ltd (4571) Related Businessweek News

No Related Businessweek News Found

nanocarrier co ltd (4571) Details

NanoCarrier Co., Ltd. researches and develops various pharmaceuticals for the treatment of cancer in Japan. The company’s products include Nanoplatin for the treatment of pancreatic, solid, and non small cell lung cancer; DACH-Platin Micelle for the treatment of bowel cancer; Epirubicin Micelle; and Paclitaxel Micelle for the treatment of stomach and breast cancer. It also develops Sensor Linked Micelle, small interfering RNA Micelle, and Protein Micelle, as well as Docetaxel Micelle for the treatment of breast, non-small cell lung, uterus, ovarian, and prostatic cancer. The company was founded in 1996 and is headquartered in Kashiwa, Japan.

40 Employees
Last Reported Date: 06/26/14
Founded in 1996

nanocarrier co ltd (4571) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanocarrier co ltd (4571) Key Developments

NanoCarrier Co., Ltd. Presents at Mizuho New York Healthcare Conference 2015, Mar-02-2015

NanoCarrier Co., Ltd. Presents at Mizuho New York Healthcare Conference 2015, Mar-02-2015 . Venue: Omni Berkshire Place, 21 East 52nd Street at Madison Ave, New York, NY 10022, United States. Speakers: Ichiro Nakatomi, Chief Executive Officer, President and Representative Director.

NanoCarrier Co., Ltd. Announces Non-Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Full Year Ending March 31, 2015

NanoCarrier Co., Ltd. announced non-consolidated earnings results for the nine months ended December 31, 2014. For the period, the company reported net sales of JPY 358,720,000 compared to JPY 444,402,000 a year ago. Ordinary income was JPY 40,390,000 compared to ordinary loss of JPY 632,672,000 a year ago. Gross operating loss was JPY 921,668,000 compared to JPY 84,532,000 a year ago. Profit before income taxes was JPY 39,715,000 compared to loss before income taxes of JPY 632,700,000 a year ago. Net income was JPY 36,663,000 compared to net loss of JPY 634,515,000 a year ago. Net income per diluted share was JPY 0.91. The company provided earnings guidance for the full year ending March 31, 2015. For the year, the company expects net sales of JPY 560 million, operating loss of JPY 1,029 million, ordinary loss of JPY 1,029 million and net loss of JPY 1,070 million or JPY 26.57 per share.

NanoCarrier Co., Ltd. to Report Q3, 2015 Results on Feb 13, 2015

NanoCarrier Co., Ltd. announced that they will report Q3, 2015 results on Feb 13, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4571:JP ¥1,193.00 JPY +3.00

4571 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4571.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4571 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 125.0x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 95.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOCARRIER CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at